Cargando…
The hypoxia signalling pathway in haematological malignancies
Haematological malignancies are tumours that affect the haematopoietic and the lymphatic systems. Despite the huge efforts to eradicate these tumours, the percentage of patients suffering resistance to therapies and relapse still remains significant. The tumour environment favours drug resistance of...
Autores principales: | Irigoyen, Marta, García-Ruiz, Juan Carlos, Berra, Edurne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482702/ https://www.ncbi.nlm.nih.gov/pubmed/28415662 http://dx.doi.org/10.18632/oncotarget.15981 |
Ejemplares similares
-
Targeting hypoxia in solid and haematological malignancies
por: Harris, Bill, et al.
Publicado: (2022) -
DUBs, New Members in the Hypoxia Signaling clUb
por: Schober, Amelie S., et al.
Publicado: (2016) -
Components of the Lectin Pathway of Complement in Haematologic Malignancies
por: Cedzyński, Maciej, et al.
Publicado: (2020) -
Tuberculosis in Patients with Haematological Malignancies
por: Anibarro, Luis, et al.
Publicado: (2014) -
The Wnt/β-catenin signalling pathway in Haematological Neoplasms
por: Yu, Siwei, et al.
Publicado: (2022)